CoChat

Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas

Open access
Krug, Brian, De Jay, Nicolas, Harutyunyan, Ashot S., Deshmukh, Shriya, Marchione, Dylan M., Guilhamon, Paul, Bertrand, Kelsey C., Mikael, Leonie G., McConechy, Melissa K., Chen, Carol C.L., Khazaei, Sima, Koncar, Robert F., Agnihotri, Sameer, Faury, Damien, Ellezam, Benjamin, Weil, Alexander G., Ursini-Siegel, Josie, De Carvalho, Daniel D., Dirks, Peter B., Lewis, Peter W., Salomoni, Paolo, Lupien, Mathieu, Arrowsmith, Cheryl, Lasko, Paul F., Garcia, Benjamin A., Kleinman, Claudia L., Jabado, Nada, Mack, Stephen C. · 2019 · Cancer Cell
Cited by 239

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Summary High-grade gliomas (HGG) defined by histone 3 K27M driver mutations exhibit global loss of H3K27 trimethylation and reciprocal gain of H3K27 acetylation, respectively shaping repressive and active chromatin landscapes. We generated tumor-derived isogenic models bearing this mutation and show that it leads to pervasive H3K27ac deposition across the genome. In turn, active enhancers and promoters are not created de novo and instead reflect the epigenomic landscape of the cell of origin. H3K27ac is enriched at repeat elements, resulting in their increased expression, which in turn can be further amplified by DNA demethylation and histone deacetylase inhibitors providing an exquisite therapeutic vulnerability. These agents may therefore modulate anti-tumor immune responses as a therapeutic modality for this untreatable disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2019.04.004

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 29 references

Research works printed but not linked: 39

  1. Akhtar-Zaidi, 2012, Epigenomic enhancer profiling defines a signature of colon cancer, Science, 336, 736, 10.1126/science.1217277 · DOI · Paper page
  2. Alves dos Santos, 2011, En1 and Wnt signaling in midbrain dopaminergic neuronal development, Neural Dev., 6, 23, 10.1186/1749-8104-6-23 · DOI · Paper page
  3. Bao, 2015, Repbase update, a database of repetitive elements in eukaryotic genomes, Mobile DNA, 6, 11, 10.1186/s13100-015-0041-9 · DOI · Paper page
  4. Baylin, 2016, Epigenetic determinants of cancer, Cold Spring Harb Perspect. Biol., 8, 10.1101/cshperspect.a019505 · DOI · Paper page
  5. Bechet, 2014, Specific detection of methionine 27 mutation in histone 3 variants (H3K27M) in fixed tissue from high-grade astrocytomas, Acta Neuropathol., 128, 733, 10.1007/s00401-014-1337-4 · DOI
  6. Belgnaoui, 2011, Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter, Curr. Opin. Immunol., 23, 564, 10.1016/j.coi.2011.08.001 · DOI · Paper page
  7. Bestor, 2004, Transposon silencing and imprint establishment in mammalian germ cells, Cold Spring Harb Symp. Quant Biol., 69, 381, 10.1101/sqb.2004.69.381 · DOI · Paper page
  8. Bickel, 2010, Subsampling methods for genomic inference, Ann. Appl. Statistics, 4, 1660, 10.1214/10-AOAS363 · DOI · Paper page
  9. Borodovsky, 2013, 5-Azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft, Oncotarget, 4, 1737, 10.18632/oncotarget.1408 · DOI · Paper page
  10. Bourc'his, 2004, Meiotic catastrophe and retrotransposon reactivation in male germ cells lacking Dnmt3L, Nature, 431, 96, 10.1038/nature02886 · DOI · Paper page
  11. Carroll, 2014, Impact of artifact removal on ChIP quality metrics in ChIP-seq and ChIP-exo data, Front. Genet., 5, 75, 10.3389/fgene.2014.00075 · DOI · Paper page
  12. Creyghton, 2010, Histone H3K27ac separates active from poised enhancers and predicts developmental state, Proc. Natl. Acad. Sci. U S A, 107, 21931, 10.1073/pnas.1016071107 · DOI · Paper page
  13. de Koning, 2011, Repetitive elements may comprise over two-thirds of the human genome, PLoS Genet., 7, e1002384, 10.1371/journal.pgen.1002384 · DOI · Paper page
  14. Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics, 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
  15. Elsasser, 2015, Histone H3.3 is required for endogenous retroviral element silencing in embryonic stem cells, Nature, 522, 240, 10.1038/nature14345 · DOI · Paper page
  16. Filbin, 2018, Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq, Science, 360, 331, 10.1126/science.aao4750 · DOI · Paper page
  17. Goke, 2015, Dynamic transcription of distinct classes of endogenous retroviral elements marks specific populations of early human embryonic cells, Cell Stem Cell, 16, 135, 10.1016/j.stem.2015.01.005 · DOI · Paper page
  18. Jo, 2015, Faster single-end alignment generation utilizing multi-thread for BWA, Biomed Mater Eng., 26, S1791
  19. Jones, 2019, Epigenetic therapy in immune-oncology, Nat. Rev. Cancer, 19, 151, 10.1038/s41568-019-0109-9 · DOI · Paper page
  20. Langmead, 2012, Fast gapped-read alignment with Bowtie 2, Nat. Methods, 9, 357, 10.1038/nmeth.1923 · DOI · Paper page
  21. Lee, 2014, PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors, Nat. Genet., 46, 1227, 10.1038/ng.3095 · DOI · Paper page
  22. Li, 2009, The sequence alignment/map format and SAMtools, Bioinformatics, 25, 2078, 10.1093/bioinformatics/btp352 · DOI · Paper page
  23. Lin, 2016, Active medulloblastoma enhancers reveal subgroup-specific cellular origins, Nature, 530, 57, 10.1038/nature16546 · DOI · Paper page
  24. Lu, 2016, Histone H3K36 mutations promote sarcomagenesis through altered histone methylation landscape, Science, 352, 844, 10.1126/science.aac7272 · DOI · Paper page
  25. Machold, 2011, Genes expressed in Atoh1 neuronal lineages arising from the r1/isthmus rhombic lip, Gene Expr. Patterns, 11, 349, 10.1016/j.gep.2011.03.007 · DOI
  26. Mack, 2018, Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling, Nature, 553, 101, 10.1038/nature25169 · DOI · Paper page
  27. Matys, 2006, TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes, Nucleic Acids Res., 34, D108, 10.1093/nar/gkj143 · DOI · Paper page
  28. Nagaraja, 2017, Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma, Cancer Cell, 31, 10.1016/j.ccell.2017.03.011 · DOI · Paper page
  29. Ramsey, 2010, Genome-wide histone acetylation data improve prediction of mammalian transcription factor binding sites, Bioinformatics, 26, 2071, 10.1093/bioinformatics/btq405 · DOI · Paper page
  30. Roulois, 2015, DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts, Cell, 162, 961, 10.1016/j.cell.2015.07.056 · DOI · Paper page
  31. Saint-Andre, 2016, Models of human core transcriptional regulatory circuitries, Genome Res., 26, 385, 10.1101/gr.197590.115 · DOI · Paper page
  32. Schlee, 2007, c-MYC impairs immunogenicity of human B cells, Adv. Cancer Res., 97, 167, 10.1016/S0065-230X(06)97007-9 · DOI
  33. Sidoli, 2016, Complete workflow for analysis of histone post-translational modifications using bottom-up mass spectrometry: from histone extraction to data analysis, J. Vis. Exp., 10.3791/54112 · DOI · Paper page
  34. Solovyov, 2018, Global cancer transcriptome quantifies repeat element polarization between immunotherapy responsive and T cell suppressive classes, Cell Rep., 23, 512, 10.1016/j.celrep.2018.03.042 · DOI · Paper page
  35. Sonoda, 2001, Homologous DNA recombination in vertebrate cells, Proc Natl Acad Sci U S A, 98, 8388, 10.1073/pnas.111006398 · DOI
  36. van der Maaten, 2008, Visualizing data using t-SNE, J. Mach. Learn. Res., 9, 2579
  37. Whyte, 2013, Master transcription factors and mediator establish super-enhancers at key cell identity genes, Cell, 153, 307, 10.1016/j.cell.2013.03.035 · DOI · Paper page
  38. Yamashita, 2018, Demethylation and epigenetic modification with 5-azacytidine reduces IDH1 mutant glioma growth in combination with temozolomide, Neuro Oncol.
  39. Zhu, 2017, Daam2 driven degradation of VHL promotes gliomagenesis, Elife, 6, 10.7554/eLife.31926 · DOI

Cited by

Metadata

Authors
Krug, B., De Jay, N., Harutyunyan, A. S., Deshmukh, S., Marchione, D. M., Guilhamon, P., Bertrand, K. C., Mikael, L. G., McConechy, M. K., Chen, C. C. L., Khazaei, S., Koncar, R. F., Agnihotri, S., Faury, D., Ellezam, B., Weil, A. G., Ursini-Siegel, J., De Carvalho, D. D., Dirks, P. B., Lewis, P. W., Salomoni, P., Lupien, M., Arrowsmith, C., Lasko, P. F., Garcia, B. A., Kleinman, C. L., Jabado, N., & Mack, S. C.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2019-05
Volume
35
Issue
5
Pages
782-797.e8
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2946243434
Cited by
239
References
29
FWCI
11.81
Type
journal article
Language
en
Update notices
erratum (2019-09-16)
Open access
bronze
Licence
Funders
  • National Institutes of Health (T32GM008275, TL1TR001880, P01-CA196539)
  • Canadian Institutes of Health Research (FDN-154307, EP1-120608, PJT-156086, MOP-286756)
  • Children's Brain Tumor Foundation
  • Cancer Prevention and Research Institute of Texas (RR170023)
  • Génome Québec
  • Fonds de Recherche du Québec - Santé
  • Alex's Lemonade Stand Foundation for Childhood Cancer
  • Baylor College of Medicine
  • Genome Canada
  • Bear Necessities Pediatric Cancer Foundation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.